课题基金 / 基金详情

LIGAND-RECEPTOR SYSTEMS

LIGAND-RECEPTOR SYSTEMS
配体受体系统
批准号:
7724229
负责人:
LARRY A. SKLAR
金额:
$1.61万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2009-03-31

项目摘要

项目成果

LARRY A. SKLAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We have begun to examine both receptors and signaling molecules displayed on beads for flow cytometry (Nolan and Sklar, 1998; Sklar et al. 2000). We have shown conditions under which his-tagged receptors may be bound to Ni2+ beads and bind ligand. We have also shown that solublized receptors may be reconstituted with heterotrimeric G proteins (subunits from Neubig) and arrestins (Prossnitz) for fluorescence, and potentially for flow cytometric analysis. We have attempted to use arrestin, receptors, as well as biotinylated receptor tail peptides as bait on beads. We are examining biotinylated anti-his antibodies instead of chelated Ni2+ beads.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagy Scientific Core
Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC)
Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC)
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
  • 批准号:
    8693254
  • 项目类别:
  • 资助金额:
    $46.26万
  • 财政年份:
    2014
  • 负责人:
    LARRY A. SKLAR
  • 依托单位:
国内基金
海外基金
坡模酸通过抑制β-arrestin2介导的M2型巨噬细胞极化抗肝纤维化的机制研究
  • 批准号:
    2026JJ81069
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    朱萱
  • 依托单位:
电针刺激ST36通过DRD1/β-arrestin1信 号通路抑制炎症性骨丢失的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    刘冠峤
  • 依托单位:
电针激活β-arrestin 1/IFN通路促进“冷-热”免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    时佳琪
  • 依托单位:
电针激活β-arrestin 1/IFN通路促进"冷-热"免疫表型转化协同IDO抑制剂治疗MSS肠癌的机制研究